SCHEMBL283035

SCHEMBL283035

CNC1CCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL429455 1.00
SCHEMBL283034 1.00
Methane SCHEMBL28591036 0.97
SCHEMBL487100 0.92
Hydrochloric Acid SCHEMBL29133641 0.90
SCHEMBL8182891 0.90
SCHEMBL25401428 0.79
SCHEMBL26095297 0.79
SCHEMBL17392981 0.79
SCHEMBL10340288 0.77 NOS2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 283 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110981838-B 5-imine-tetrahydrofuryl methylamine derivative and preparation method and application thereof 中国人民解放军第四军医大学 2023-03-24 CN claimed
CN-110669058-A Tricyclic quinolone carboxylic acid and preparation method thereof 江西农业大学 2020-01-10 CN claimed
US-8202876-B2 Compounds and compositions as protein kinase inhibitors IRM LLC (BM) 2012-06-19 US claimed
US-20100029605-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2010-02-04 US claimed
EP-2057146-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2009-05-13 EP claimed
WO-2008042639-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2008-04-10 WO claimed
CN-114072393-B 3-Amino-4H-benzo [ E ] [1,2,4] thiadiazine 1, 1-dioxide derivatives as MRGX2 inhibitors 索伦特治疗有限责任公司 2025-05-27 CN disclosed
CN-113226356-B Activation of pyruvate kinase R 诺沃挪第克健康护理股份公司 2025-03-04 CN disclosed
CN-119504587-A Indenoazepine compound, preparation method and medical application thereof 贵州民族大学 2025-02-25 CN disclosed
CN-116234552-B Dual modulators of mGluR5 and 5-HT2A receptors and uses thereof (株)倍宝尊 2025-02-25 CN disclosed
CN-118891039-A Selective G protein coupled receptor kinase 5 inhibitors, compositions and methods of use 普渡研究基金会 2024-11-01 CN disclosed
CN-115745960-B Compound containing quinolinone amide, preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2024-08-30 CN disclosed
CN-118414337-A Pyrazolopyrimidine derivative and anticancer pharmaceutical composition containing same as active ingredient 韩国化学研究院 2024-07-30 CN disclosed
EP-0801083-A2 Improved functionalized resin for chemical synthesis PFIZER INC. (US) 1997-10-15 EP disclosed
WO-1997023508-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1997-07-03 WO disclosed
EP-0158922-A2 Tetrahydrofuran-2-ylmethylamines BAYER AG (DE) 1985-10-23 EP disclosed
US-4491671-A Process for the preparation of N-substituted imido-dicarboxylic acid diaryl esters BAYER AKTIENGESELLSCHAFT (DE) 1985-01-01 US disclosed
US-4348331-A FROM THE HYDROCHLORIDE OF A PRIMARY AMINE AND AN ARYL ESTER HALIDE BAYER AKTIENGESELLSCHAFT (DE) 1982-09-07 US disclosed
US-4210648-A ANTIULCEROGENICS, SECRETION INHIBITORS BOEHRINGER INGELHEIM GMBH (DE) 1980-07-01 US disclosed
US-4210648-A ANTIULCEROGENICS, SECRETION INHIBITORS BOEHRINGER INGELHEIM GMBH (DE) 1980-07-01 US disclosed